Stratus Therapeutics
Albert Paszek is an accomplished executive in the biotechnology and pharmaceutical manufacturing sectors, currently serving as Vice President of Manufacturing at Garuda Therapeutics since October 2023. Previous roles include Vice President of Manufacturing Science and Technology at Mustang Bio, where responsibilities included overseeing the setup of commercial-scale CAR-T therapies, and Executive Director of Manufacturing Science and Technology at the same company, focusing on team development and process verification. Albert has extensive experience in manufacturing for cell and gene therapies, demonstrated during tenure as Senior Director at both Abeona Therapeutics and Alexion Pharmaceuticals, where significant projects included the construction of GMP facilities and the approval of therapeutic products. Educational credentials include a PhD in Quantitative Genetics, a Post-Doctoral Associate in Genomics, and additional certifications in Lean Six Sigma and project management.
Stratus Therapeutics
4 followers
Stratus Therapeutics is redefining regenerative medicine with Stratus Prime™ — a platform for full hematopoietic system renewal, on demand. Our proprietary product, ST-101, includes both hematopoietic stem cells (Prime HSCs™) and hematopoietic progenitor cells (Prime HPCs™) to drive durable, long-term engraftment with full hematopoietic system restoration, while supporting near-term immune reconstitution.